Robert Paul Discordia, Chief Operating Officer at Corbus Pharmaceuticals Holdings, Inc. (CRBP), bought 2,840 shares at $3.54 ($10K) on 2020-03-17, disclosed to the SEC on 2020-03-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |